SIMCERE PHARMAC. GRP LTDSIMCERE PHARMAC. GRP LTDSIMCERE PHARMAC. GRP LTD

SIMCERE PHARMAC. GRP LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.98 B‬EUR
0.04EUR
‪98.81 M‬EUR
‪894.24 M‬EUR
‪570.43 M‬
Beta (1Y)
0.55
Employees (FY)
‪6.58 K‬
Change (1Y)
−443 −6.30%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About SIMCERE PHARMACEUTICAL GRP LTD


CEO
Jin Sheng Ren
Headquarters
Nanjing
Founded
1995
ISIN
HK0000658531
FIGI
BBG00Y04NC95
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as S2P.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SIMCERE PHARMAC. GRP LTD stocks are traded under the ticker S2P.
We've gathered analysts' opinions on SIMCERE PHARMAC. GRP LTD future price: according to them, S2P price has a max estimate of 1.59 EUR and a min estimate of 1.00 EUR. Watch S2P chart and read a more detailed SIMCERE PHARMAC. GRP LTD stock forecast: see what analysts think of SIMCERE PHARMAC. GRP LTD and suggest that you do with its stocks.
S2P reached its all-time high on Jan 13, 2023 with the price of 1.56 EUR, and its all-time low was 0.57 EUR and was reached on Mar 7, 2024. View more price dynamics on S2P chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SIMCERE PHARMAC. GRP LTD financials in yearly and quarterly reports right on TradingView.
SIMCERE PHARMAC. GRP LTD is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
S2P net income for the last half-year is ‪37.29 M‬ EUR, while the previous report showed ‪59.14 M‬ EUR of net income which accounts for −36.94% change. Track more SIMCERE PHARMAC. GRP LTD financial stats to get the full picture.
Yes, S2P dividends are paid annually. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (TTM)% is 1.62%. Tracking SIMCERE PHARMAC. GRP LTD dividends might help you take more informed decisions.
SIMCERE PHARMAC. GRP LTD dividend yield was 2.46% in 2024, and payout ratio reached 55.26%. The year before the numbers were 2.61% and 58.03% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 20, 2025, the company has ‪6.58 K‬ employees. See our rating of the largest employees — is SIMCERE PHARMAC. GRP LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SIMCERE PHARMAC. GRP LTD EBITDA is ‪164.66 M‬ EUR, and current EBITDA margin is 18.43%. See more stats in SIMCERE PHARMAC. GRP LTD financial statements.
Like other stocks, S2P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SIMCERE PHARMAC. GRP LTD stock right from TradingView charts — choose your broker and connect to your account.